SEC Comment Letter 0000000000-24-003687 to BIOVIE INC. (BIVI)

BIOVIE INC.
Date: April 5, 2024 · CIK: 0001580149 · Accession: 0000000000-24-003687

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-39015

Date

April 5, 2024

Author

Joanne Wendy Kim

Form

UPLOAD

Company

BIOVIE INC.

Letter

United States securities and exchange commission logo April 5, 2024 Joanne Wendy Kim Chief Financial Officer BIOVIE INC. 680 W Nye Lane, Suite 204 Carson City, NV 89703 Re:BIOVIE INC. Form 10-K for the Fiscal Year Ended June 30, 2023 Filed August 16, 2023 File No. 001-39015 Dear Joanne Wendy Kim: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
April 5, 2024
Joanne Wendy Kim
Chief Financial Officer
BIOVIE INC.
680 W Nye Lane, Suite 204
Carson City, NV 89703
Re:BIOVIE INC.
Form 10-K for the Fiscal Year Ended June 30, 2023
Filed August 16, 2023
File No. 001-39015
Dear Joanne Wendy Kim:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io